Beacon Pointe Advisors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,537
| Closed | -$235K | – | 1192 |
|
|
2024
Q4 | $235K | Buy |
1,537
+149
| +11% | +$22.8K | ﹤0.01% | 1084 |
|
|
2024
Q3 | $269K | Sell |
1,388
-285
| -17% | -$55.2K | ﹤0.01% | 1050 |
|
|
2024
Q2 | $388K | Sell |
1,673
-2,606
| -61% | -$604K | ﹤0.01% | 948 |
|
|
2024
Q1 | $923K | Sell |
4,279
-263
| -6% | -$56.7K | 0.01% | 712 |
|
|
2023
Q4 | $1.18M | Sell |
4,542
-13,614
| -75% | -$3.52M | 0.01% | 614 |
|
|
2023
Q3 | $4.67M | Buy |
18,156
+16,806
| +1,245% | +$4.32M | 0.06% | 284 |
|
|
2023
Q2 | $385K | Buy |
1,350
+82
| +6% | +$23.4K | 0.01% | 792 |
|
|
2023
Q1 | $353K | Sell |
1,268
-271
| -18% | -$75.4K | 0.01% | 871 |
|
|
2022
Q4 | $426K | Buy |
1,539
+271
| +21% | +$75K | 0.01% | 745 |
|
|
2022
Q3 | $341K | Buy |
1,268
+12
| +1% | +$3.23K | 0.01% | 761 |
|
|
2022
Q2 | $255K | Sell |
1,256
-12,207
| -91% | -$2.48M | 0.01% | 884 |
|
|
2022
Q1 | $2.84M | Buy |
13,463
+10,369
| +335% | +$2.18M | 0.04% | 372 |
|
|
2021
Q4 | $742K | Buy |
3,094
+1,003
| +48% | +$241K | 0.02% | 447 |
|
|
2021
Q3 | $592K | Sell |
2,091
-655
| -24% | -$185K | 0.01% | 508 |
|
|
2021
Q2 | $951K | Buy |
2,746
+1,766
| +180% | +$612K | 0.03% | 347 |
|
|
2021
Q1 | $271K | Buy |
+980
| New | +$271K | 0.02% | 410 |
|
|
2019
Q2 | – | Sell |
-7,472
| Closed | -$1.77M | – | 205 |
|
|
2019
Q1 | $1.77M | Buy |
+7,472
| New | +$1.77M | 0.66% | 46 |
|